{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T07:28:23Z","timestamp":1789889303527,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T00:00:00Z","timestamp":1376697600000},"content-version":"vor","delay-in-days":2877,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.virol.2005.06.043","type":"journal-article","created":{"date-parts":[[2005,8,3]],"date-time":"2005-08-03T23:13:47Z","timestamp":1123110827000},"page":"91-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection"],"prefix":"10.1016","volume":"341","author":[{"given":"S.","family":"Coulibaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Br\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mayrhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gerencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.G.","family":"Falkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.virol.2005.06.043_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2005.06.043_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"issue":"16","key":"10.1016\/j.virol.2005.06.043_bib3","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.virol.2005.06.043_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1086\/315190","article-title":"Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge","volume":"181","author":"Bray","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virol.2005.06.043_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/intimm\/5.6.647","article-title":"Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus","volume":"5","author":"Chen","year":"1993","journal-title":"Int. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2005.06.043_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0042-6822(03)00520-8","article-title":"The genomic sequence of ectromelia virus, the causative agent of mousepox","volume":"317","author":"Chen","year":"2003","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.virol.2005.06.043_bib7","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/eji.1830161203","article-title":"Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response","volume":"16","author":"Coupar","year":"1986","journal-title":"Eur. J. Immunol."},{"issue":"3\u20134","key":"10.1016\/j.virol.2005.06.043_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-1135(96)00072-7","article-title":"A monoclonal blocking-ELISA for detection of orthopoxvirus antibodies in feline sera","volume":"52","author":"Czerny","year":"1996","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.virol.2005.06.043_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/jvi.66.1.386-398.1992","article-title":"Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans","volume":"66","author":"Demkowicz","year":"1992","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2005.06.043_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1073\/pnas.262668999","article-title":"Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines","volume":"100","author":"Drexler","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.virol.2005.06.043_bib11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/viro.2000.0203","article-title":"Vaccinia virus-related events and phenotypic changes after infection of dendritic cells derived from human monocytes","volume":"268","author":"Drillien","year":"2000","journal-title":"Virology"},{"issue":"Pt. 8","key":"10.1016\/j.virol.2005.06.043_bib12","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1099\/vir.0.79998-0","article-title":"Modified vaccinia virus Ankara induces moderate activation of human dendritic cells","volume":"85","author":"Drillien","year":"2004","journal-title":"J. Gen. Virol."},{"issue":"6979","key":"10.1016\/j.virol.2005.06.043_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"issue":"8719","key":"10.1016\/j.virol.2005.06.043_bib14","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0140-6736(90)92387-W","article-title":"Fatal cowpox-like virus infection transmitted by cat","volume":"336","author":"Eis-Hubinger","year":"1990","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.virol.2005.06.043_bib15","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.4049\/jimmunol.163.12.6762","article-title":"Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion","volume":"163","author":"Engelmayer","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2005.06.043_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1067\/mai.2002.128052","article-title":"Smallpox vaccination: risk considerations for patients with atopic dermatitis","volume":"110","author":"Engler","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5 Pt. 2","key":"10.1016\/j.virol.2005.06.043_bib17","first-page":"553","article-title":"Mousepox (infectious ectromelia): past, present, and future","volume":"31","author":"Fenner","year":"1981","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.virol.2005.06.043_bib18","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virus","volume":"78","author":"Fogg","year":"2004","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2005.06.043_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.virol.2005.06.043_bib20","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2005.06.043_bib21","series-title":"Vaccines","article-title":"Smallpox and vaccinia","author":"Henderson","year":"1999"},{"issue":"22","key":"10.1016\/j.virol.2005.06.043_bib22","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","article-title":"Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"Henderson","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.virol.2005.06.043_bib23","first-page":"283","article-title":"An attenuated strain of vaccinia virus (MVA). Successful intramuscular immunization against vaccinia and variola (author's transl.)","volume":"230","author":"Hochstein-Mintzel","year":"1975","journal-title":"Zentralbl. Bakteriol. [Orig. A]"},{"issue":"7","key":"10.1016\/j.virol.2005.06.043_bib24","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1128\/jvi.71.7.4997-5002.1997","article-title":"Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line","volume":"71","author":"Holzer","year":"1997","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2005.06.043_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.virol.2005.06.043_bib26","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virol.2005.06.043_bib27","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.1128\/JVI.79.10.6554-6559.2005","article-title":"Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus","volume":"79","author":"Jackson","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2005.06.043_bib28","first-page":"16","article-title":"Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus: II. Pathogenesis","volume":"37","author":"Jacoby","year":"1987","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.virol.2005.06.043_bib47","series-title":"Preliminary characterization of vaccinia immune globulin. Abstract","author":"Jones-Trower","year":"2004"},{"issue":"11","key":"10.1016\/j.virol.2005.06.043_bib29","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1073\/pnas.0406671102","article-title":"Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8","volume":"102","author":"Kidokoro","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Pt. A","key":"10.1016\/j.virol.2005.06.043_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0076-6879(81)78139-4","article-title":"Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays","volume":"78","author":"Langford","year":"1981","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.virol.2005.06.043_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.2000.0750","article-title":"Antibody neutralization of the extracellular enveloped form of vaccinia virus","volume":"280","author":"Law","year":"2001","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.virol.2005.06.043_bib32","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1073\/pnas.0409846102","article-title":"Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo","volume":"102","author":"Legrand","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2005.06.043_bib33","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl. Bakteriol., Hyg. 1, Abt. Orig., B"},{"issue":"22","key":"10.1016\/j.virol.2005.06.043_bib34","doi-asserted-by":"crossref","first-page":"12471","DOI":"10.1128\/JVI.78.22.12471-12479.2004","article-title":"Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4","volume":"78","author":"McCurdy","year":"2004","journal-title":"J. Virol."},{"issue":"Pt. 5","key":"10.1016\/j.virol.2005.06.043_bib35","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2005.06.043_bib36","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1128\/jvi.62.10.3772-3778.1988","article-title":"Vaccinia virus gene D8 encodes a virion transmembrane protein","volume":"62","author":"Niles","year":"1988","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.virol.2005.06.043_bib37","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1128\/JVI.76.15.7713-7723.2002","article-title":"Immunogenicity and safety of defective vaccinia virus Lister: comparison with modified vaccinia virus Ankara","volume":"76","author":"Ober","year":"2002","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2005.06.043_bib38","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3201\/eid0706.010602","article-title":"Developing new smallpox vaccines","volume":"7","author":"Rosenthal","year":"2001","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virol.2005.06.043_bib39","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1006\/viro.1998.9039","article-title":"The genomic sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins","volume":"243","author":"Shchelkunov","year":"1998","journal-title":"Virology"},{"issue":"Pt. 12","key":"10.1016\/j.virol.2005.06.043_bib40","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"8","key":"10.1016\/j.virol.2005.06.043_bib41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0264-410X(94)90215-1","article-title":"Characteristics of an attenuated vaccinia virus strain, LC16m0, and its recombinant virus vaccines","volume":"12","author":"Sugimoto","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.06.043_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0042-6822(91)90480-Y","article-title":"Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins","volume":"181","author":"Takahashi-Nishimaki","year":"1991","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2005.06.043_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","article-title":"NYVAC: a highly attenuated strain of vaccinia virus","volume":"188","author":"Tartaglia","year":"1992","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.virol.2005.06.043_bib44","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nm916","article-title":"Clonal vaccinia virus grown in cell culture as a new smallpox vaccine","volume":"9","author":"Weltzin","year":"2003","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.virol.2005.06.043_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"issue":"13","key":"10.1016\/j.virol.2005.06.043_bib46","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205004058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205004058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:38:29Z","timestamp":1758584309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682205004058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0042682205004058"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2005.06.043","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2005.06.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}